These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26630012)

  • 1. Midregional Proadrenomedullin Improves Risk Stratification beyond Surgical Risk Scores in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Csordas A; Nietlispach F; Schuetz P; Huber A; Müller B; Maisano F; Taramasso M; Moarof I; Obeid S; Stähli BE; Cahenzly M; Binder RK; Liebetrau C; Möllmann H; Kim WK; Hamm C; Lüscher TF
    PLoS One; 2015; 10(12):e0143761. PubMed ID: 26630012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.
    Sinning JM; Wollert KC; Sedaghat A; Widera C; Radermacher MC; Descoups C; Hammerstingl C; Weber M; Stundl A; Ghanem A; Widder J; Vasa-Nicotera M; Mellert F; Schiller W; Bauersachs J; Zur B; Holdenrieder S; Welz A; Grube E; Pencina MJ; Nickenig G; Werner N; Kempf T
    Am Heart J; 2015 Oct; 170(4):821-9. PubMed ID: 26386807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality prediction following transcatheter aortic valve replacement: A quantitative comparison of risk scores derived from populations treated with either surgical or percutaneous aortic valve replacement. The Israeli TAVR Registry Risk Model Accuracy Assessment (IRRMA) study.
    Halkin A; Steinvil A; Witberg G; Barsheshet A; Barkagan M; Assali A; Segev A; Fefer P; Guetta V; Barbash IM; Kornowski R; Finkelstein A
    Int J Cardiol; 2016 Jul; 215():227-31. PubMed ID: 27128536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement.
    Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
    Am J Cardiol; 2013 Mar; 111(6):891-7. PubMed ID: 23337835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profiles and correlates of mortality in nonagenarians with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Escárcega RO; Baker NC; Lipinski MJ; Koifman E; Kiramijyan S; Magalhaes MA; Gai J; Torguson R; Satler LF; Pichard AD; Waksman R
    Am Heart J; 2016 Mar; 173():118-25. PubMed ID: 26920604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of Risk Prediction After Transcatheter Aortic Valve Replacement by Combining Frailty With Conventional Risk Scores.
    Schoenenberger AW; Moser A; Bertschi D; Wenaweser P; Windecker S; Carrel T; Stuck AE; Stortecky S
    JACC Cardiovasc Interv; 2018 Feb; 11(4):395-403. PubMed ID: 29471953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
    Dvir D; Waksman R; Barbash IM; Kodali SK; Svensson LG; Tuzcu EM; Xu K; Minha S; Alu MC; Szeto WY; Thourani VH; Makkar R; Kapadia S; Satler LF; Webb JG; Leon MB; Pichard AD
    J Am Coll Cardiol; 2014 Jan; 63(3):269-79. PubMed ID: 24140659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in Risk Stratification in Transcatheter Aortic Valve Implantation Using a Combination of the Tumor Marker CA125 and the Logistic EuroSCORE.
    Husser O; Núñez J; Burgdorf C; Holzamer A; Templin C; Kessler T; Bodi V; Sanchis J; Pellegrini C; Luchner A; Maier LS; Schmid C; Lüscher TF; Schunkert H; Kastrati A; Hilker M; Hengstenberg C
    Rev Esp Cardiol (Engl Ed); 2017 Mar; 70(3):186-193. PubMed ID: 27623490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-regional pro-adrenomedullin (MR-proADM) and mid-regional pro-atrial natriuretic peptide (MR-proANP) in severe aortic valve stenosis: association with outcome after transcatheter aortic valve implantation (TAVI).
    Baldenhofer G; Laule M; Mockel M; Sanad W; Knebel F; Dreger H; Leonhardt F; Sander M; Grubitzsch H; Baumann G; Stangl K; Stangl V
    Clin Chem Lab Med; 2017 Feb; 55(2):275-283. PubMed ID: 27522619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
    Williams M; Kodali SK; Hahn RT; Humphries KH; Nkomo VT; Cohen DJ; Douglas PS; Mack M; McAndrew TC; Svensson L; Thourani VH; Tuzcu EM; Weissman NJ; Kirtane AJ; Leon MB
    J Am Coll Cardiol; 2014 Apr; 63(15):1522-8. PubMed ID: 24561149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic effect of the TyG index on patients with severe aortic stenosis following transcatheter aortic valve replacement: a retrospective cohort study.
    Li W; Li H; Peng S; Li J; Feng Y; Peng Y; Wei J; Zhao Z; Xiong T; Yang H; Song C; Bai L; Yao Y; Chen F; Yin Y; Chen M
    Cardiovasc Diabetol; 2024 Aug; 23(1):312. PubMed ID: 39182080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
    Pedowska-Włoszek J; Kostrubiec M; Kurnicka K; Ciurzynski M; Palczewski P; Pruszczyk P
    Thromb Res; 2013 Nov; 132(5):506-10. PubMed ID: 24060192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pre-procedural serum albumin levels on outcome of patients undergoing transcatheter aortic valve replacement.
    Koifman E; Magalhaes MA; Ben-Dor I; Kiramijyan S; Escarcega RO; Fang C; Torguson R; Okubagzi P; Negi SI; Baker NC; Minha S; Corso PJ; Shults C; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2015 May; 115(9):1260-4. PubMed ID: 25759105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Functional Versus Organic Baseline Mitral Regurgitation on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Replacement.
    Kiramijyan S; Koifman E; Asch FM; Magalhaes MA; Didier R; Escarcega RO; Negi SI; Baker NC; Jerusalem ZD; Gai J; Torguson R; Okubagzi P; Wang Z; Shults CC; Ben-Dor I; Corso PJ; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2016 Mar; 117(5):839-46. PubMed ID: 26873331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of albumin to Traditional Risk Score Improved Prediction of Mortality in Individuals Undergoing Transcatheter Aortic Valve Replacement.
    Grossman Y; Barbash IM; Fefer P; Goldenberg I; Berkovitch A; Regev E; Fink N; Ben-Zekry S; Brodov Y; Kogan A; Guetta V; Raanani E; Segev A
    J Am Geriatr Soc; 2017 Nov; 65(11):2413-2417. PubMed ID: 28941287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification using lean body mass in patients undergoing transcatheter aortic valve replacement.
    Hioki H; Watanabe Y; Kozuma K; Yamamoto M; Naganuma T; Araki M; Tada N; Shirai S; Yamanaka F; Higashimori A; Mizutani K; Tabata M; Takagi K; Ueno H; Hayashida K;
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1365-1373. PubMed ID: 29469953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Risk in Transcatheter Aortic Valve Implantation: Comparative Analysis of EuroSCORE II and Established Risk Stratification Tools.
    Silaschi M; Conradi L; Seiffert M; Schnabel R; Schön G; Blankenberg S; Reichenspurner H; Diemert P; Treede H
    Thorac Cardiovasc Surg; 2015 Sep; 63(6):472-8. PubMed ID: 25191764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement.
    Lindman BR; Zajarias A; Maniar HS; Miller DC; Suri RM; Arnold SV; Webb J; Svensson LG; Kodali S; Xu K; Ayele GM; Lin F; Wong SC; Babaliaros V; Thourani VH; Douglas PS; Lim S; Leon MB; Mack MJ
    Heart; 2015 Oct; 101(20):1656-64. PubMed ID: 26264371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between mitral regurgitation and transcatheter aortic valve replacement with the CoreValve Revalving System: a multicenter registry.
    Bedogni F; Latib A; De Marco F; Agnifili M; Oreglia J; Pizzocri S; Latini RA; Lanotte S; Petronio AS; De Carlo M; Ettori F; Fiorina C; Poli A; Cirri S; De Servi S; Ramondo A; Tarantini G; Marzocchi A; Fiorilli R; Klugmann S; Ussia GP; Tamburino C; Maisano F; Brambilla N; Colombo A; Testa L
    Circulation; 2013 Nov; 128(19):2145-53. PubMed ID: 24088530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of baseline cigarette smoking status on clinical outcome after transcatheter aortic valve replacement.
    Abawi M; van Gils L; Agostoni P; van Mieghem NM; Kooistra NHM; van Dongen CS; van Jaarsveld RC; de Jaegere PPT; Doevendans PAFM; Stella PR
    Catheter Cardiovasc Interv; 2019 Nov; 94(6):795-805. PubMed ID: 30901147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.